Potential Therapy May Better Prepare Older Patients Before Stem Cell Transplant

Potential Therapy May Better Prepare Older Patients Before Stem Cell Transplant

286898

Potential Therapy May Better Prepare Older Patients Before Stem Cell Transplant

JSP191, an investigational therapy by Jasper Therapeutics, showed promising efficacy as a conditioning agent to prepare older patients with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) for a stem cell transplant. These are the early findings of an ongoing open-label Phase 1 trial, called JSP-CP-003 (NCT04429191), which is currently investigating the safety, tolerability, and efficacy of adding JSP191 to a standard conditioning regimen for older adults with AML or MDS before they undergo a…

You must be logged in to read/download the full post.